Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Oct;17(10):881-8.
doi: 10.1097/jgp.0b013e3181b4bf4a.

Change in cognitive functioning following acute antidepressant treatment in late-life depression

Affiliations
Randomized Controlled Trial

Change in cognitive functioning following acute antidepressant treatment in late-life depression

Michelle E Culang et al. Am J Geriatr Psychiatry. 2009 Oct.

Abstract

Objective: Selective Serotonin Reuptake Inhibitors (SSRIs) are the most commonly prescribed medications for geriatric depression. The association of late-life depression and cognitive impairment has been well documented. However, there have been few placebo-controlled trials examining the impact of SSRIs on cognitive functioning.

Design: Prepost neuropsychological (NP) data collected as part of an 8-week, double-blind, placebo-controlled trial of citalopram in depressed patients aged 75 years and older were used to examine change in cognitive functioning.

Setting: University-affiliated outpatient psychiatry clinics.

Participants: One hundred seventy-four community-dwelling men and women aged 75 years or older with nonpsychotic unipolar depression.

Measurements: NP assessments included mental status (Mini-Mental State Examination), psychomotor speed (Wechsler Adult Intelligence Scale-III Digit Symbol Subtest), reaction time (Choice Reaction Time), visual-spatial skill (Judgment of Line Orientation), executive functioning (Stroop Color/Word Test), and memory (Buschke Selective Reminding Test).

Results: Differences in the pattern of change by treatment group depended on responder status. Citalopram nonresponders were the only group to decline on verbal learning and psychomotor speed. Citalopram responders showed significant improvement in visuospatial functioning, when compared with nonresponders in either condition, but their improvement was not greater than responders on placebo. Citalopram responders showed greater improvement on psychomotor speed than citalopram nonresponders, but their improvement was not greater than placebo responders or nonresponders.

Conclusions: Medication may have a deleterious effect on some aspects of cognition among patients aged 75 years and older who have not responded. This suggests that patients should not be maintained on a medication if they have not had an adequate response.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Change in cognitive performance from pre to post-treatment in the (a) placebo condition and (b) citalopram condition across six neuropsychological tests.

References

    1. Salloway S, Malloy P, Kohn R, et al. MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology. 1996;46:1567–1574. - PubMed
    1. Kramer-Ginsberg E, Greenwald BS, Krishnan KRR, et al. Neuropsychological Functioning and MRI Signal Hyperintensities in Geriatric Depression. Am J Psychiatry. 1999;156:438–444. - PubMed
    1. Gallassi R, Di Sarro R, Morreale A, et al. Memory impairment in patients with late-onset major depression: The effect of antidepressant therapy. Journal of Affective Disorders. 2006;91:243–250. - PubMed
    1. Butters MA, Whyte EM, Nebes RD, et al. The nature and determinants of neuropsychological functioning in late-life depression. Archives of General Psychiatry. 2004;61:587–595. - PubMed
    1. Lesser I, Boone K, Mehringer C, et al. Cognition and white matter hyperintensities in older depressed patients. American Journal of Psychiatry. 1996;153:1280–1287. - PubMed

Publication types